Special Issue of AJMC Spotlights Health IT

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Rzk149 on January 19, 2019 at 05:25PM A special edition of the American Journal of Managed Care (AJMC) shifts the spotlight to health care information technology, bringing features from experts on electronic health records, interoperability and patient-facing technology. Included in the January issue are articles on the tools […]

United Healthcare Sues Pharma Companies

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HkO4rB on January 19, 2019 at 04:55PM Citing a conspiracy to “fix, increase, stabilize, or maintain prices of generic drugs,” United Healthcare Services (UHS) has filed a lawsuit against a host of drugmakers alleging they violated antitrust laws, Bloomberg Law reports. UHS in its lawsuit demands that the […]

Lack of Standardized Definition of Value Detrimental to Push, Article Says

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2CvjVjC on January 19, 2019 at 04:25PM Bringing about a standardized definition of value is key to pushing forward health technology assessments in the 21st century, a recent opinion piece on Morning Consult states. Three key questions that must be answered, the author states, are: What is value-based […]

Despite Much Health Care Data, Obstacles Complicate Their Use

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2CsVO58 on January 19, 2019 at 03:55PM U.S. regulations on health care data are stymieing the potential of data garnered through electronic health records, a recent study in the Journal of the American Medical Informatics Association suggests. The study, according to a FierceHealthcare report, suggests regulations have yet […]

Opinion: U.S. Shouldn’t Outsource Drug Value Assessments Through an IPI

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2RGmvO7 on January 19, 2019 at 03:55PM A recent opinion article published on STAT says the U.S. should conduct in-house value assessments for prescription drugs rather than look to other countries’ prices as proposed by President Donald Trump’s administration. The administration last year proposed an international pricing index […]